Liminatus Pharma, Inc. (LIMNW) stock
LIMNWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as LIMN
$0.04+0.00 (0.00%)
Close on Oct 30, 2026Market cap $189.39MP/E –Yield –
Liminatus Pharma revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
No revenue figures for Liminatus Pharma
Liminatus Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.